Altered MAPK Signaling in Major Depression: The Role of MKP-1
The topic for this week’s Friday Research Seminar Series will be physiology and pharmacology. All faculty members and students are invited to attend.
Objectives
- Explain some of the known cellular and molecular pathophysiological hallmarks of major depressive disorder (MDD)
- Identify brain areas and cellular mechanisms targeted by current depression research
- Describe usage of molecular biology techniques in combination with preclinical behavioral models in identifying new therapeutic targets for treatment of MDD
- Define the role of negative regulation of MAPK signaling pathway in the development of depressive state and antidepressant treatment
Vanja Duric, Ph.D.
Assistant professor – Physiology and pharmacology
Des Moines University (DMU) prohibits discrimination in employment, educational programs, and activities on the basis of race, national origin, color, creed, religion, sex, age, disability, veteran status, sexual orientation, gender identity, or associational preference. The University also affirms its commitment to providing equal opportunities and equal access to University facilities. Individuals with disabilities are encouraged to attend DMU sponsored events. If you have questions/concerns, please the DMU Continuing Medical Education office at 515-271-1541 or cme@dmu.edu.